miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.
Fernández-Tussy P, Cardelo MP, Zhang H, Sun J, Price NL, Boutagy NE, Goedeke L, Cadena-Sandoval M, Xirouchaki CE, Brown W, Yang X, Pastor-Rojo O, Haeusler RA, Bennett AM, Tiganis T, Suárez Y, Fernández-Hernando C.
Fernández-Tussy P, et al. Among authors: suarez y.
JCI Insight. 2024 Aug 27;9(19):e168476. doi: 10.1172/jci.insight.168476.
JCI Insight. 2024.
PMID: 39190492
Free PMC article.